These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10193138)

  • 1. Treatment considerations in the opioid dependent patient.
    Wartenberg AA
    Med Health R I; 1999 Mar; 82(3):91-4. PubMed ID: 10193138
    [No Abstract]   [Full Text] [Related]  

  • 2. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 4. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substitutions therapy of opiate addiction in Denmark].
    Ishøy T; Iversen C
    Ugeskr Laeger; 2003 Sep; 165(38):3620-3. PubMed ID: 14556394
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alternative therapy.
    Hicks M
    Nurs Stand; 2000 Jul 26-Aug 1; 14(45):18. PubMed ID: 11974198
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating opioid dependence--new data and new opportunities.
    O'Connor PG
    N Engl J Med; 2000 Nov; 343(18):1332-4. PubMed ID: 11058680
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating opioid dependence.
    Stimmel B
    N Engl J Med; 2001 Feb; 344(7):530; author reply 530-1. PubMed ID: 11221618
    [No Abstract]   [Full Text] [Related]  

  • 10. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
    Madden A; Lea T; Bath N; Winstock AR
    Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute pain during drug-assisted rehabilitation].
    Fredheim OM; Nøstdahl T; Nordstrand B; Høivik T; Rygnestad T; Borchgrevink PC
    Tidsskr Nor Laegeforen; 2010 Apr; 130(7):738-40. PubMed ID: 20379336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
    Moody DE
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient opioid addiction treatment using buprenorphine.
    Roberson CM
    Ala Nurse; 2010; 37(2):13-6; quiz 17. PubMed ID: 20666206
    [No Abstract]   [Full Text] [Related]  

  • 20. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.